| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 41077 |
| 1 | ADALIMUMAB | 15269 |
| 2 | DUPILUMAB | 11789 |
| 3 | METHOTREXATE SODIUM | 6368 |
| 4 | METHOTREXATE | 6266 |
| 5 | TIRZEPATIDE | 5616 |
| 6 | TERIPARATIDE | 5069 |
| 7 | INTERFERON BETA-1A | 3787 |
| 8 | PREDNISONE | 3114 |
| 9 | ERGOCALCIFEROL | 3012 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZOPAPOGENE IMADENOVEC | 20 | 0.5000 |
| 1 | RILONACEPT | 134 | 0.1158 |
| 2 | OCRELIZUMAB AND HYALURONIDASE | 53 | 0.1062 |
| 3 | ERGOCALCIFEROL | 3012 | 0.1013 |
| 4 | PEGVALIASE-PQPZ | 794 | 0.0932 |
| 5 | ASFOTASE ALFA | 881 | 0.0854 |
| 6 | LENACAPAVIR SODIUM | 43 | 0.0850 |
| 7 | GLATIRAMER ACETATE INJECTION | 391 | 0.0830 |
| 8 | PEGINTERFERON BETA-1A | 1065 | 0.0813 |
| 9 | OLEZARSEN SODIUM | 77 | 0.0813 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 42491 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 11789 |
| 2 | GLP-1 Receptor Agonist [EPC] | 8607 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 6135 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5666 |
| 5 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 5616 |
| 6 | Parathyroid Hormone Analog [EPC] | 5069 |
| 7 | Corticosteroid [EPC] | 4956 |
| 8 | Interferon beta [EPC] | 4831 |
| 9 | Vitamin C [EPC] | 3927 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 198 | 0.2878 |
| 1 | Adrenocorticotropic Hormone [EPC] | 132 | 0.1475 |
| 2 | PCSK9 Inhibitor [EPC] | 2686 | 0.1043 |
| 3 | Provitamin D2 Compound [EPC] | 3012 | 0.1012 |
| 4 | Endoglycosidase [EPC] | 179 | 0.0966 |
| 5 | Phenylalanine Metabolizing Enzyme [EPC] | 794 | 0.0932 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 881 | 0.0854 |
| 7 | Melanocortin 4 Receptor Agonist [EPC] | 22 | 0.0772 |
| 8 | Interleukin-17A Antagonist [EPC] | 2683 | 0.0720 |
| 9 | Skin Test Antigen [EPC] | 91 | 0.0483 |